Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 18164144.
- Also identified by DOI 10.1016/j.drugalcdep.2007.11.004 and PMC identifier 2293271.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The dopamine precursor levodopa has shown some, albeit relatively weak, promise in treating cocaine dependence. This study sought to identify the most appropriate behavioral therapy platform for levodopa pharmacotherapy by evaluating its effect when administered in combination with behavioral platforms of varying intensities. A total of 161 treatment-seeking cocaine dependent subjects received sustained release levodopa/carbidopa (400/100mg bid, Sinemet) or placebo delivered in combination with Clinical Management (ClinMan); ClinMan+cognitive behavioral therapy (CBT); or ClinMan+CBT+voucher-based reinforcement therapy (VBRT) in a 12-week randomized, placebo-controlled, double-blind (for medication condition) trial. Medication compliance was monitored with riboflavin (100mg/capsule) and the Medication Event Monitoring System. Protocol compliance was addressed in weekly, 10-min nurse-delivered ClinMan sessions. Weekly, 1-h CBT sessions focused on coping skills training. VBRT (with escalating reinforcer value) provided cash-valued vouchers contingent on cocaine-negative urine toxicology results. Urine benzoylecgonine assays collected thrice-weekly were analyzed by intention-to-treat criteria using generalized linear mixed models. Levodopa main effects were found on all outcome measures of cocaine use. Contrasts testing the levodopa-placebo difference within each behavioral platform found reliable effects, favoring levodopa, only in the VBRT platform. Levodopa treatment with vouchers produced higher proportions of cocaine-negative urines and longer periods of consecutive abstinence compared to other treatment combinations. This is the first study to find a significant treatment effect for levodopa and, in doing so, to demonstrate that the magnitude of this effect is dependent upon conditions of the behavioral therapy platform. The data support use of levodopa with abstinence-based reinforcement therapy as one efficacious combination in cocaine dependence disorder treatment.
Medical subject headings
- Adult
- Cocaine-Related Disorders
- Cocaine-Related Disorders/diagnosis
- Cocaine-Related Disorders/drug therapy
- Cocaine-Related Disorders/epidemiology
- Cocaine-Related Disorders/therapy
- Cognitive Behavioral Therapy
- Cognitive Behavioral Therapy/methods
- Combined Modality Therapy
- Diagnostic and Statistical Manual of Mental Disorders
- Dopamine Agonists
- Dopamine Agonists/therapeutic use
- Double-Blind Method
- Female
- Humans
- Levodopa
- Levodopa/therapeutic use
- Male
- Patient Acceptance of Health Care
- Patient Acceptance of Health Care/statistics & numerical data
- Patient Compliance
- Patient Compliance/statistics & numerical data
- Retention, Psychology
- Severity of Illness Index